(Q37762904)

22 August 2017

1 reference

title

The expanding spectrum of biological actions of vitamin D. (English)

1 reference

22 August 2017

0 references

0 references

Alberto Ortiz

4

0 references

author name string

Jorge Rojas-Rivera

1

1 reference

22 August 2017

C De La Piedra

2

1 reference

22 August 2017

Ana Ramos

3

1 reference

22 August 2017

Jesús Egido

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

3 June 2010

1 reference

Nephrology Dialysis Transplantation

22 August 2017

published in

1 reference

22 August 2017

volume

25

1 reference

22 August 2017

issue

9

1 reference

22 August 2017

page(s)

2850-2865

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

22 August 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D therapy for chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Isolated adrenocorticotropic hormone deficiency presenting with hypercalcemia in a patient on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

The role of vitamin D in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Muscle strength in the elderly: its relation to vitamin D metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney disease mineral and bone disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D and the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Osteomalacia and Hyperparathyroid Bone Disease in Patients with Nephrotic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

A new mechanism for induced vitamin D deficiency in calcium deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Calcimimetics and calcilytics--fooling the calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

The noncalciotropic actions of vitamin D: recent clinical developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Low vitamin d levels predict stroke in patients referred to coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Maternal vitamin D deficiency increases the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Calcium/vitamin D supplementation and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Preeclampsia and the risk of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

25-hydroxyvitamin D levels and the risk of mortality in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

25-hydroxyvitamin D levels, race, and the progression of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Association of oral calcitriol with improved survival in nondialyzed CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D receptor as a drug discovery target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Noncalcemic Actions of Vitamin D Receptor Ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Protein kinase C and mitogen-activated protein kinase are required for 1,25-dihydroxyvitamin D3-stimulated Egr induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblasts treated with 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Regulation of gp330/megalin expression by vitamins A and D

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Renin-angiotensin system and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Expanding targets of vitamin D receptor activation: downregulation of several RAS components in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Renoprotective role of the vitamin D receptor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Evidence for abnormal translational regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase activity in the hyp-mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Arterial calcifications and bone histomorphometry in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

A bimodal association of vitamin D levels and vascular disease in children on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Potential for vitamin D receptor agonists in the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D receptor activators can protect against vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Intervention in autoimmunity: the potential of vitamin D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D: its role and uses in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D deficiency in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Update on vascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Management of cardiovascular disease risk in chronic inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D status in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

1,25-dihydroxyvitamin D deficiency predicts poorer outcome after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D, glucose, insulin, and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D and glucose metabolism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Identification of a Vitamin D response element in the human insulin receptor gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D replacement in Asians with diabetes may increase insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

Vitamin D levels and patient outcome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ313

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ313

1 reference

22 August 2017

1 reference